Qutenza Patch - Our early experience

Hdl Handle:
http://hdl.handle.net/10147/275594
Title:
Qutenza Patch - Our early experience
Authors:
Weekes, G; O’Brien, J; Murphy, K; Keavney, J; Pollard, V
Publisher:
Irish Medical Journal
Journal:
Irish Medical Journal
Issue Date:
Mar-2013
URI:
http://hdl.handle.net/10147/275594
Abstract:
Qutenza is a high potency capsaicin topical patch which has been recommended for the treatment of peripheral neuropathic pain. The aim of this study was to assess our selected patients’ response to Qutenza application. All patients had their dynamic pain score recorded prior to application and were asked to fill in a standardised questionnaire for three months post application. Patients were also asked to document any changes to the character of their pain, changes in sleep, activities of daily living and mood as well as any changes to their medication usage. 21 patients had Qutenza applied in a 5 month period. 17 patients completed the questionnaire in a 5 month period. We found that the mean overall reduction in pain score at 3 months was 32.7%. 8 of our patients (47%) reported improved sleep, activities of daily living and mood. 6 patients (35%) reported a reduction in medication use, while 7 (41%) reported an improvement in the character of their pain
Item Type:
Article
Language:
en
Keywords:
PAIN MANAGEMENT

Full metadata record

DC FieldValue Language
dc.contributor.authorWeekes, Gen_GB
dc.contributor.authorO’Brien, Jen_GB
dc.contributor.authorMurphy, Ken_GB
dc.contributor.authorKeavney, Jen_GB
dc.contributor.authorPollard, Ven_GB
dc.date.accessioned2013-03-21T13:56:49Z-
dc.date.available2013-03-21T13:56:49Z-
dc.date.issued2013-03-
dc.identifier.urihttp://hdl.handle.net/10147/275594-
dc.description.abstractQutenza is a high potency capsaicin topical patch which has been recommended for the treatment of peripheral neuropathic pain. The aim of this study was to assess our selected patients’ response to Qutenza application. All patients had their dynamic pain score recorded prior to application and were asked to fill in a standardised questionnaire for three months post application. Patients were also asked to document any changes to the character of their pain, changes in sleep, activities of daily living and mood as well as any changes to their medication usage. 21 patients had Qutenza applied in a 5 month period. 17 patients completed the questionnaire in a 5 month period. We found that the mean overall reduction in pain score at 3 months was 32.7%. 8 of our patients (47%) reported improved sleep, activities of daily living and mood. 6 patients (35%) reported a reduction in medication use, while 7 (41%) reported an improvement in the character of their painen_GB
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.subjectPAIN MANAGEMENTen_GB
dc.titleQutenza Patch - Our early experienceen_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.